Comparison of mucosal and mucoperiosteal wound cover for the treatment of medication-related osteonecrosis of the jaw lesions: a retrospective cohort study

[1]  P. Choung,et al.  Extensive Surgical Procedures Result in Better Treatment Outcomes for Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Osteoporosis. , 2017, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[2]  K. Sano,et al.  Denosumab-related osteonecrosis of the jaw in a patient with bone metastases of prostate cancer: A case report and literature review , 2017, Oncology letters.

[3]  B. Hohlweg-Majert,et al.  Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study. , 2017, International journal of oral and maxillofacial surgery.

[4]  C. Gay-Escoda,et al.  Surgical treatment vs. conservative treatment in intravenous bisphosphonate-related osteonecrosis of the jaws. Systematic review , 2017, Journal of clinical and experimental dentistry.

[5]  M. Ehrenfeld,et al.  Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study. , 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[6]  G. Rabelo,et al.  Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution. , 2015, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[7]  M. Ehrenfeld,et al.  Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. , 2015, International journal of oral and maxillofacial surgery.

[8]  B. Hohlweg-Majert,et al.  Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ). , 2015, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[9]  G. Ottaviani,et al.  A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). , 2014, Oral oncology.

[10]  T. Dodson,et al.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. , 2014, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[11]  M. Schwaiger,et al.  Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis? , 2014, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[12]  M. Metzger,et al.  Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients. , 2012, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[13]  M. Miccoli,et al.  Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retrospective survey of 347 cases. , 2012, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[14]  G. Mast,et al.  Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. , 2012, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[15]  A. Hemprich,et al.  The saxon bisphosphonate register - therapy and prevention of bisphosphonate-related osteonecrosis of the jaws. , 2012, Oral oncology.

[16]  R. Ewers,et al.  Factors influencing surgical treatment of bisphosphonate‐related osteonecrosis of the jaws , 2012, Head & neck.

[17]  G. Bedogni,et al.  Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis. , 2011, Oral oncology.

[18]  T. Mücke,et al.  Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws , 2011, Journal of Cancer Research and Clinical Oncology.

[19]  S. Hoefert,et al.  Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw. , 2011, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[20]  B. Frerich,et al.  The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[21]  E. Nkenke,et al.  Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up , 2010, Supportive Care in Cancer.

[22]  L. Assael,et al.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. , 2009, Australian endodontic journal : the journal of the Australian Society of Endodontology Inc.

[23]  E. Carlson,et al.  The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. , 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[24]  L. Assael,et al.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. , 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[25]  G. Hortobagyi,et al.  Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  K. Antoniadis,et al.  Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. , 2007, American journal of otolaryngology.

[27]  A. Kolk,et al.  In vivo tetracycline labeling of bone: an intraoperative aid in the surgical therapy of osteoradionecrosis of the mandible. , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[28]  C. Czerny,et al.  Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients , 2006, Wiener klinische Wochenschrift.

[29]  R. Marx,et al.  Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. , 2005, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[30]  T. J. Rosenberg,et al.  Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[31]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[32]  M. Kovacs,et al.  Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. , 1996, The New England journal of medicine.

[33]  R. Marx.  Osteoradionecrosis: a new concept of its pathophysiology. , 1983, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[34]  J. Salleron,et al.  Denosumab‐related osteonecrosis of the jaw: A retrospective study , 2018, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[35]  I. Kim,et al.  Evaluation of the bisphosphonate effect on stem cells derived from jaw bone and long bone rabbit models: A pilot study. , 2018, Archives of oral biology.

[36]  R. Ewers,et al.  Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs). , 2013, Oral oncology.

[37]  K. Wolff,et al.  Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. , 2011, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[38]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[39]  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. , 2007, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.